TITLE

US policy on stem cells

AUTHOR(S)
Feldbaum, Carl B.
PUB. DATE
October 2001
SOURCE
Nature Biotechnology;Oct2001, Vol. 19 Issue 10, p911
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Explores the Unites States policy on stem cell research. Guidelines for stem cell research funding; Limitations on the cell lines approved for federal research; Impact on scientists' work.
ACCESSION #
8782596

 

Related Articles

  • RUMBLINGS.  // Crain's Detroit Business;7/14/2008, Vol. 24 Issue 28, p30 

    The article presents information on constitutional amendment to expand stem cell research in Michigan, which is spending $2 million to garner nearly 600,000 signatures. According to Larry Owen, chairman of the stem cell committee, the campaign hopes to raise $10 million to $20 million to educate...

  • Power-Laws and the Use of Pluripotent Stem Cell Lines. Schuldt, Bernhard M.; Guhr, Anke; Lenz, Michael; Kobold, Sabine; MacArthur, Ben D.; Schuppert, Andreas; Löser, Peter; Müller, Franz-Josef // PLoS ONE;Jan2013, Vol. 8 Issue 1, Special section p1 

    It is widely accepted that the (now reversed) Bush administration's decision to restrict federal funding for human embryonic stem cell (hESC) research to a few "eligible" hESC lines is responsible for the sustained preferential use of a small subset of hESC lines (principally the H1 and H9...

  • Connecticut's Stem Cell Research Program. Galvin, J. Robert // Connecticut Medicine;May2009, Vol. 73 Issue 5, p297 

    The article emphasizes the initiative of Connecticut to fund stem cell research. It states the passage of the Connecticut General Assembly and the ratification of the Public Act 05-149, an act that allows stem cell research and bans human cloning, by Governor M. Jodi Rell in 2005 in order to...

  • Point: The Potential of Stem Cell Research. Pearson, John // Points of View: Stem Cell Research;12/31/2017, p5 

    This article presents an argument on the potential of stem cell research. Therapeutic treatments involving stem cells show tremendous potential for the treatment of complex diseases related to genetic disorders that now afflict millions of people. Federal funding for such research should be...

  • Counterpoint: The Promises and Pitfalls of Stem Cell Research. Clouthier, Kris // Points of View: Stem Cell Research;12/31/2017, p6 

    This article presents an argument on the problems associated with stem cell research. Stem-cell research has much to offer in the way of treatments, or even cures, for devastating diseases and injuries. However, research using human embryonic stem cells--which can be acquired only by destroying...

  • Cellular Divide. Begley, Sharon; Murr, Andrew; Check, Erika; Rogers, Adam // Newsweek (Atlantic Edition);7/16/2001 (Atlantic Edition), Vol. 138 Issue 3, p46 

    Discusses the controversy over research on stem cells taken from human embryos in the United States. Mention that the embryos are often left over at in vitro fertilization centers; Topic of the moral and ethical issues surrounding the research; Question of whether President George W. Bush will...

  • In Search of Stem Cells. Begley, Sharon; Reno, Jamie // Newsweek (Atlantic Edition);9/10/2001 (Atlantic Edition), Vol. 138 Issue 11, p59 

    Discusses the availability of stem cells which are approved for research funding by the United States government. List of 64 stem cell lines released by the National Institutes of Health; Number of cell lines which are owned by small companies that do not have the manpower to make them...

  • California.  // Pharmaceutical Technology Europe;Nov2008, Vol. 20 Issue 11, p65 

    The article reports on the significance of the forward-thinking reputation, well-funded research universities and world leadership in stem cell research and green energy in assuring continued business operation of biotechnology companies in California in 2008. Continued financial support for...

  • Fight over veto is near: President and Congressional Democratic Leaders Face Off on Embryo-Killing Research.  // National Right to Life News;Apr2007, Vol. 34 Issue 4, p1 

    The article discusses the efforts of U.S. Democratic legislators to overturn a policy implemented by U.S. President George W. Bush which prohibits federal funding of stem cell research. Senate Majority Leader Larry Reid will introduce a bill that will authorize federal funding of the type of...

  • Heterogeneity of leukemia-initiating capacity of chronic myelogenous leukemia stem cells. Bin Zhang; Ling Li; Yinwei Ho; Min Li; Marcucci, Guido; Wei Tong; Bhatia, Ravi; Zhang, Bin; Li, Ling; Ho, Yinwei; Li, Min; Tong, Wei // Journal of Clinical Investigation;3/1/2016, Vol. 126 Issue 3, p975 

    Chronic myelogenous leukemia (CML) results from transformation of a long-term hematopoietic stem cell (LTHSC) by expression of the BCR-ABL fusion gene. However, BCR-ABL-expressing LTHSCs are heterogeneous in their capacity as leukemic stem cells (LSCs). Although discrepancies in proliferative,...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics